… GLOBE NEWSWIRE) -- The global marine pharmaceuticals market size … held a major share of approximately 30% of … , increasing investment in marine research and biotechnology, and … collaborations with academic and international pharmaceutical firms. Key …

… supply chain, and investing in the local communities … anywhere in the state finance necessary infrastructure upgrades … Cervania. “Their increased investment underscores our ability to … General Assembly, North Carolina Biotechnology Center, North Carolina …

… field (e.g., biotechnology). These products represent … foreign official agencies to private purchasers out of stock … services. Financial services - Includes financial intermediary and … data/intl-trade-investment/international-trade-goods-and-services …

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug- …

… Research. The global AI in biotechnology market is driven … revenue of approximately 30% share of the market. … approaches. Moreover, increasing investments, demand for personalized medicines … companies, which heavily invested in AI solutions. Moreover …

… laws. If you invested in MoonLake, you … behalf of investors in MoonLake common stock. The case … is a clinical-stage biotechnology company focused on developing … international law firm representing plaintiffs in securities class actions and shareholder …

… Pharma Group International Ascentage Pharma Group International (NASDAQ: … global partnerships and other relationships with numerous leading biotechnology … of operations or financial condition. These … or otherwise. Contacts Investor Relations: Stella Yang …

… International strengthens supply chain integration and drives growth in the global … investing in R&D, climate-controlled facilities, and biotechnology … -largest share in the global mushroom market … mushrooms is attracting investments in smart technologies …

Tokyo, Japan and Cambridge, UK, 19 November 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) announces that its Board of Directors have decided to replace the current Restricted Share Unit (“RSU”) Plan with the Employee Stock Ownership Plan …

… biotechnology, and the increasing demand for sustainable nutrition. As manufacturers, investors … Brands are increasingly investing in taste, … markets represent key investment opportunities for global manufacturers … breakouts, company share analysis, and …